Filing Details

Accession Number:
0001415889-21-001300
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 20:01:11
Reporting Period:
2021-03-03
Accepted Time:
2021-03-03 20:01:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591312 I Bassil Dahiyat C/O Xencor, Inc.
111 W. Lemon Ave
Monrovia CA 91016
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-03 2,850 $44.88 141,064 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 7,868 restricted stock units.
  2. The weighted average sale price for the transaction reported was $44.8803, and the range of prices were between $44.8801 and $45.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 232 shares acquired in June 2020 and 178 shares acquired in December 2020.